Duncker Streett & Co’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.63K | Hold |
417
| – | – | ﹤0.01% | 469 |
|
|
2025
Q1 | $2.67K | Hold |
417
| – | – | ﹤0.01% | 463 |
|
|
2024
Q4 | $3.35K | Hold |
417
| – | – | ﹤0.01% | 484 |
|
|
2024
Q3 | $5.27K | Hold |
417
| – | – | ﹤0.01% | 431 |
|
|
2024
Q2 | $5.28K | Hold |
417
| – | – | ﹤0.01% | 435 |
|
|
2024
Q1 | $1.99K | Hold |
417
| – | – | ﹤0.01% | 446 |
|
|
2023
Q4 | $2K | Hold |
417
| – | – | ﹤0.01% | 453 |
|
|
2023
Q3 | $3.02K | Hold |
417
| – | – | ﹤0.01% | 446 |
|
|
2023
Q2 | $3.1K | Hold |
417
| – | – | ﹤0.01% | 450 |
|
|
2023
Q1 | $2.89K | Hold |
417
| – | – | ﹤0.01% | 436 |
|
|
2022
Q4 | $4.29K | Hold |
417
| – | – | ﹤0.01% | 448 |
|
|
2022
Q3 | $8K | Hold |
417
| – | – | ﹤0.01% | 405 |
|
|
2022
Q2 | $21K | Hold |
417
| – | – | 0.01% | 362 |
|
|
2022
Q1 | $31K | Hold |
417
| – | – | 0.01% | 347 |
|
|
2021
Q4 | $60K | Hold |
417
| – | – | 0.01% | 325 |
|
|
2021
Q3 | $86K | Hold |
417
| – | – | 0.02% | 301 |
|
|
2021
Q2 | $89K | Hold |
417
| – | – | 0.02% | 295 |
|
|
2021
Q1 | $76K | Buy |
417
+180
| +76% | +$32.8K | 0.01% | 306 |
|
|
2020
Q4 | $26K | Hold |
237
| – | – | 0.01% | 384 |
|
|
2020
Q3 | $26K | Buy |
+237
| New | +$26K | 0.01% | 368 |
|
|
2019
Q1 | – | Sell |
-50
| Closed | -$2K | – | 574 |
|
|
2018
Q4 | $2K | Hold |
50
| – | – | ﹤0.01% | 545 |
|
|
2018
Q3 | $2K | Hold |
50
| – | – | ﹤0.01% | 565 |
|
|
2018
Q2 | $1K | Hold |
50
| – | – | ﹤0.01% | 582 |
|
|
2018
Q1 | $2K | Buy |
+50
| New | +$2K | ﹤0.01% | 576 |
|